Biofrontera (BFRI) News Today $0.88 +0.03 (+3.46%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Biofrontera Advances Phase 2b Clinical Trial for Ameluz® in Acne Treatment, Final Patient Visit CompletedAugust 25, 2025 | quiverquant.comQBiofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne VulgarisAugust 25, 2025 | globenewswire.comRosalind Advisors, Inc. Increases Stake in Biofrontera Inc.August 15, 2025 | gurufocus.comBiofrontera Inc. Reports Revenue Growth Amid Strategic RestructuringAugust 15, 2025 | msn.comBiofrontera Revenue Jumps 15% in Q2August 14, 2025 | theglobeandmail.comBiofrontera Q2 Revenue Jumps 15%August 14, 2025 | theglobeandmail.comBiofrontera Inc. (BFRI) Q2 2025 Earnings Conference Call TranscriptAugust 14, 2025 | seekingalpha.comBiofrontera Inc. Reports Second Quarter 2025 Financial Results and Business UpdateAugust 13, 2025 | quiverquant.comQBiofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business UpdateAugust 13, 2025 | globenewswire.comBiofrontera Appoints New Chief Commercial OfficerAugust 13, 2025 | theglobeandmail.comA Look at Biofrontera's Upcoming Earnings ReportAugust 12, 2025 | benzinga.comBiofrontera Inc. Appoints George Jones as Chief Commercial OfficerAugust 11, 2025 | globenewswire.comBiofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025August 4, 2025 | globenewswire.comBiofrontera restructures relationship with Biofrontera AG, backed by $11M investment - Seeking AlphaJuly 2, 2025 | seekingalpha.comBiofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment - Seeking AlphaJuly 2, 2025 | seekingalpha.comBiofrontera Restructures U.S. Rights with $11M InvestmentJune 30, 2025 | tipranks.comBiofrontera restructures relationship with Biofrontera AG, backed by $11M investmentJune 30, 2025 | msn.comBiofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million InvestmentJune 30, 2025 | globenewswire.comBIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AGJune 11, 2025 | globenewswire.comBiofrontera Updates Proxy Statement for 2025 MeetingJune 3, 2025 | tipranks.comBiofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange BookJune 3, 2025 | globenewswire.comEarnings call transcript: Biofrontera Q1 2025 sees revenue rise, stock dipsMay 18, 2025 | uk.investing.comBiofrontera Inc. faces Nasdaq delisting over share priceMay 16, 2025 | investing.comBiofrontera signals 2025 record revenue ambitions with new Ameluz patent and cost controlsMay 16, 2025 | msn.comBiofrontera Inc. (BFRI) Q1 2025 Earnings Call TranscriptMay 16, 2025 | seekingalpha.comBiofrontera Inc. (BFRI) Reports 9% Revenue Growth in Q1 2025May 16, 2025 | gurufocus.comBiofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update | ...May 15, 2025 | gurufocus.comBiofrontera Inc. (BFRI) Sees Encouraging Revenue Growth in Q1 | BFRI Stock NewsMay 15, 2025 | gurufocus.comBiofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business UpdateMay 15, 2025 | globenewswire.comBiofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne VulgarisMay 15, 2025 | globenewswire.comAn Overview of Biofrontera's EarningsMay 15, 2025 | benzinga.comBiofrontera Faces Nasdaq Non-Compliance NoticeMay 14, 2025 | tipranks.comBiofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025May 6, 2025 | gurufocus.comBiofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025 | BFRI Stock NewsMay 6, 2025 | gurufocus.comBiofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic KeratosisMay 1, 2025 | globenewswire.comBiofrontera Inc. (NASDAQ:BFRI) Q4 2024 Earnings Call TranscriptMarch 25, 2025 | msn.comBiofrontera Inc. Reports Record Sales and Strategic AdvancesMarch 24, 2025 | tipranks.comEarnings call transcript: Biofrontera Q4 2024 sees revenue growth and strategic shiftsMarch 23, 2025 | uk.investing.comBiofrontera Full Year 2024 Earnings: Misses ExpectationsMarch 22, 2025 | finance.yahoo.comBiofrontera Inc (BFRI) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amidst Financial ...March 22, 2025 | finance.yahoo.comBiofrontera Inc. Reports Record Revenue Growth in 2024March 21, 2025 | tipranks.comBiofrontera outlines 2025 growth strategies with new FDA approvals and clinical progressMarch 21, 2025 | msn.comBiofrontera Inc. (BFRI) Q4 2024 Earnings Call TranscriptMarch 21, 2025 | seekingalpha.comBiofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business UpdateMarch 21, 2025 | globenewswire.comBiofrontera Completes Patient Enrollment In Phase 3 Study Of Ameluz For Actinic KeratosesMarch 20, 2025 | nasdaq.comBiofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and TrunkMarch 18, 2025 | globenewswire.comBiofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025March 11, 2025 | globenewswire.comBiofrontera, Inc.January 23, 2025 | edition.cnn.comBiofrontera Inc. files to sell 5.72M shares of common stock for holdersJanuary 21, 2025 | markets.businessinsider.comBiofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)January 8, 2025 | globenewswire.com Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BFRI Media Mentions By Week BFRI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BFRI News Sentiment▼1.291.03▲Average Medical News Sentiment BFRI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BFRI Articles This Week▼31▲BFRI Articles Average Week Get the Latest News and Ratings for BFRI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Biofrontera and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies PLUR News Today MRSN News Today XLO News Today KLTO News Today RNXT News Today BTAI News Today ESLA News Today EGRX News Today SCYX News Today CLSD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BFRI) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access